Quantinuum reported an adjusted loss of 28 cents per share, wider than the 26-cent loss expected by analysts. Revenue reached $8 million, topping the $7.598 million estimate and rising 279% from a year earlier.
The company forecast full-year 2026 revenue of $28 million to $32 million, above the $26.485 million analyst estimate.
Quantinuum ended June with $2.1 billion in cash, cash equivalents and short-term investments.
Analysts at Rosenblatt Securities and TD Cowen maintained bullish ratings following the report. Rosenblatt reiterated its Buy rating and $155 price forecast, while TD Cowen maintained a Buy rating without assigning a price forecast.
Quantinuum A ‘Core Quantum Name To Own’: Rosenblatt
